CDZIP vs GSK · rev $16.3M vs P/E 13, $103.31B cap
Cadiz Inc. Depositary Shares (CDZIP) versus GlaxoSmithKline PLC ADR (GSK) — a side-by-side from cached financials, not a winner call.
Cadiz Inc. Depositary Shares (CDZIP) is a utilities - regulated water company listed on US.
GlaxoSmithKline PLC ADR (GSK) is a drug manufacturers - general company listed on US.
Latest reported CDZIP revenue for 2025-12-31 was $16.3M. Net income was -$34.2M. Revenue was up 69.8% from 2024-12-31 to 2025-12-31. CDZIP currently screens at market cap $0.
GSK does not have a complete income-statement cache yet.
CDZIP currently screens at market cap $0. GSK currently screens at market cap $103.31B and trailing P/E 13.5.
Not investment advice. Open the CDZIP and GSK stock pages for the full models.
Not investment advice.